Search for: "In re N.D. & M.D"
Results 21 - 40
of 196
Sort by Relevance
|
Sort by Date
6 Aug 2021, 11:00 am
F&G International Group Holdings, LLC, No. 20-cv-73 (S.D. [read post]
7 Jun 2021, 8:16 pm
M.D. [read post]
6 Jun 2021, 4:37 pm
M.D. [read post]
3 Dec 2020, 2:00 am
(N.D. [read post]
16 Jun 2020, 2:18 pm
John Reed StarkIs a company’s post-breach forensic report subject to discovery in subsequent breach related litigation? [read post]
2 Jun 2020, 12:54 am
I. du Pont de Nemours & Co. [read post]
28 May 2020, 5:29 am
Despite the confusing verbiage, these judicial rulings are a serious deviation from the text of Rule 702, as well as the Advisory Committee Note to the 2000 Amendments, which embraced the standard articulated in In re Paoli, that “any step that renders the analysis unreliable . . . renders the expert’s testimony inadmissible. [read post]
30 Mar 2020, 4:59 am
Heritage Bank (In re Hart), 564 F. [read post]
19 Mar 2020, 10:35 am
§ 157(b)(2)(A), (M), & (O). [read post]
18 Feb 2020, 9:20 am
M.D. [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
13 Dec 2019, 1:58 pm
Dean Witter, 83 F.3d 132 (6th Cir. 1996) Texas In re Wakefield, 293 B.R. 372 (N.D. [read post]
12 Sep 2019, 1:02 pm
¶ 10 & Ex. [read post]
29 Jul 2019, 7:34 pm
Alonso, M.D., Def. [read post]
8 Apr 2019, 9:35 am
Back in 2001, in the aftermath of the silicone gel breast implant litigation, I participated in a Federal Judicial Center (FJC) television production of “Science in the Courtroom, program 6” (2001). [read post]
4 Apr 2019, 12:36 pm
, 2019 WL 1437877 (N.D. [read post]
20 Dec 2018, 8:00 am
Reiche, 2018 WL 6259536 (N.D. [read post]
20 Dec 2018, 8:00 am
Reiche, 2018 WL 6259536 (N.D. [read post]
14 Sep 2018, 5:08 am
N.D. [read post]
27 Mar 2018, 5:02 pm
New York.February 23, 2018.Natalie Jean-Baptiste, Plaintiff, pro se.NCO Financial Services Inc & Access Group Inc., Defendants, represented by Michael G. [read post]
